19 - Maxwell Finland Lecture

Thursday, October 20, 2022

9:15 AM – 10:00 AM US ET

Location: Ballroom ABC (3rd Floor)

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Daniel McQuillen, MD

Senior Physician
Beth Israel Lahey Health - Lahey Hospital & Medical Center
Burlington, MA, United States

Disclosure(s): No financial relationships to disclose

Faculty(s)

Helen Boucher, MD

Dean ad interim/Chief Academic Officer
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure(s): American Society of Microbiology: Editor, AAC (Ongoing); Elsevier, Inc: Editor, ID Clinics of North America (Ongoing); Sanford Guide: Editor (Ongoing)

Slides

Disclosure(s):

Daniel McQuillen, MD: No financial relationships to disclose

Helen W. Boucher, MD: American Society of Microbiology: Editor, AAC (Ongoing); Elsevier, Inc: Editor, ID Clinics of North America (Ongoing); Sanford Guide: Editor (Ongoing)

D.A. Henderson Award
Society Citation

Learning Objectives:

At the conclusion of this session, participants will be able to:

identify the key drivers of antimicrobial resistance
recognize the impact of one health in both the problem of and optimal response to antimicrobial resistance
identify potential incentives of drug and diagnostic development to treat and detect antimicrobial resistant infections

Presentations:

9:15 AM – 9:35 AM US ET

Awards Presentation
9:35 AM – 10:00 AM US ET

Running to Stand Still: Progress and Perils with AMR
Speaker: Helen W. Boucher, MD – Tufts Medical Center